Avidity of anti-beta-2-glycoprotein I antibodies

Autoimmunity Reviews

Volumn 4, Issue 5, 2005, Pages 303-308

  Bozic B ^a,b   Cucnik S ^a   Kveder, T ^a   Rozman, B ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Affinity; Anti 2 GPI antibodies; Avidity; Pathogenicity; Standardisation

Indexed keywords

ANTIGEN; BETA2 GLYCOPROTEIN 1 ANTIBODY; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

ANTIBODY AFFINITY; ANTIBODY BLOOD LEVEL; ANTIBODY COMBINING SITE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; B LYMPHOCYTE; BINDING AFFINITY; CELLULAR IMMUNITY; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE DEFICIENCY; LABORATORY; MUTANT; NONHUMAN; PATHOGENESIS; PATHOGENICITY; REVIEW; STANDARDIZATION; THROMBOSIS;

ANIMALS; ANTIBODY AFFINITY; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS;

EID: 21244434612     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.01.001     Document Type: Review

References (40)

1. M. Galli, P. Comfurius, C. Maassen, H.C. Hemker, M.H. De Baets, and P.J.C. van Breda-Vriesman Anticardiolipin antibodies (ACA) directed not to cardiolipin but to plasma protein cofactor Lancet 335 1990 1544 1547
2. H.P. McNeil, R.J. Simpson, C.N. Chesterman, and S.A. Krilis Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H) Proc. Natl. Acad. Sci. U. S. A. 87 1990 4120 4124
3. E. Matsuura, Y. Igarashi, M. Fujimoto, K. Ichikawa, and T. Koike Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease Lancet 336 1990 177 178
4. W.A. Wilson, A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, and J.-C. Piette International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop Arthritis Rheum. 42 1999 1309 1311
5. G. Zandman-Goddard, M. Blank, Y. Sherer, M. Ehrenfeld, J. Chapman, and H. Orbach 10th international congress on antiphospholipid antibodies-summary Auto Rev. 2 2003 79 85
6. H. Wurm β2-glycoprotein I (apolipoprotein H) interactions with phospholipid vesicles Int. J. Biochem. 16 1984 511 515
7. J. Arnout, C. Wittevrongel, M. Vanrusselt, and J. Vermylen Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces Thromb. Haemost. 79 1 1998 79 86
8. G.M. Willems, M.P. Janssen, M.M.A.L. Pelsers, P. Comfurius, M. Galli, and R.F.A. Zwaal Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes Biochemistry 35 1996 13833 14427
9. T. Koike, K. Ichikawa, H. Kasahara, T. Atsumi, A. Tsutsumi, and E. Matsuura Epitopes on beta2-GPI recognized by anticardiolipin antibodies Lupus 7 Suppl. 2 1998 S14 S17
10. S.W. Reddel, Y.X. Wang, and S.A. Krilis Anti-β2-glycoprotein I autoantibodies require an antigen density threshold, consistent with bivalent binding Lupus 12 2003 37 45
11. Y. Sheng, D.A. Kandiah, and S.A. Krilis Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta-2glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity J. Immunol. 161 1998 2038 2043
12. S. Čučnik, T. Kveder, I. Križaj, B. Rozman, and B. Božič High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome Ann. Rheum. Dis. 63 2004 1478 1482
13. C.A. Janeway, P. Travers, M. Walport, and M. Shlomchik Immunobiology 5th ed. 2001 Garland Publishing New York Appendix I
14. J. Cabiedes, A.R. Cabral, and D. Alarcon-Segovia Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies J. Rheumatol. 22 1995 1899 1906
15. M. Sanmarco, C. Soler, C. Christides, D. Raoult, P.J. Weiller, and V. Gerolami Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies J. Lab. Clin. Med. 129 1997 499 506
16. L.O. Carreras, R.R. Forastiero, and M.E. Martinuzzo Which are the best biological markers of the antiphospholipid syndrome J. Autoimmun. 15 2000 163 172
17. I. Marai, B. Gilburd, M. Blank, and Y. Shoenfeld Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome Hum. Antib. 12 2003 57 62
18. D.M. Keeling, A.J. Wilson, I.J. Mackie, D.A. Isenberg, and S.J. Machin Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro J. Clin. Pathol. 46 1993 908 911
19. R.A.S. Roubey, R.A. Eisenberg, M.F. Harper, and J.B. Winfield Anticardiolipin autoantibodies recognise β2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding J. Immunol. 154 1995 954 960
20. M. Blank, A. Waisman, E. Mozes, T. Koike, and Y. Shoenfeld Characteristics and pathogenic role of anti-β2-glycoprotein I single chain Fv domains: induction of experimental antiphospholipid syndrome Int. Immunol. 11/12 1999 1917 1926
21. R.U. Chukwuocha, E.T. Hsiao, P. Shaw, J.L. Witztum, and P.P. Chen Isolation, characterization and sequence analysis of five IgG monoclonal anti-beta 2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display J. Immunol. 163 1999 4604 4611
22. L. Zhang, K. Jacobsson, K. Strom, M. Lindberg, and L. Frykberg Staphylococcus aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein I Microbiology 145 1999 177 183
23. E.E. Gharavi, H. Chaimovich, E. Cucurull, C.M. Celli, H. Tang, and W.A. Wilson Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides Lupus 8 1999 449 455
24. M. Blank, Y. Shoenfeld, S. Cabilly, Y. Heldman, M. Fridkin, and E. Katchalski-Katzir Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides Proc. Natl. Acad. Sci. U. S. A. 96 1999 5164 5168
25. M. Blank, I. Krause, M. Fridkin, N. Keller, J. Kopolovic, and I. Goldberg Bacterial induction of autoantibodies to β2-glycoprotein I accounts for the infectious etiology of antiphospholipid syndrome J. Clin. Invest. 109 2002 797 804
26. A. Tincani, L. Spatola, E. Prati, F. Allegri, P. Ferremi, and R. Cattaneo The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution J. Immunol. 157 1996 5732 5738
27. V. Regnault, E. De Maistre, D. Wahl, and T. Lecompte Monovalent binding of autoantibodies to beta2-glycoprotein I, detected using surface plasmon resonance at low antigen density Br. J. Haematol. 109 2000 187 194
28. P.G. Vlachyiannopoulos, C. Petrovas, M. Tektonidou, S. Krilis, and H.M. Moutsopoulos Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis J. Clin. Immunol. 18 1998 380 391
29. J. Arvieux, Y. Renaudineau, I. Mane, R. Perraut, S.A. Krilis, and P. Youinou Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome Thromb. Haemost. 87 2002 599 605
30. G. Reber, I. Schousboe, A. Tincani, M. Sanmarco, T. Kveder, and P. de Moerloose Inter-laboratory variability of anti-β2-glycoprotein I measurement. A collaborative study in the frame of the European forum on antiphospholipid antibodies standardization group Thromb. Haemost. 88 2002 66 73
31. S. Čučnik, I. Križaj, B. Rozman, T. Kveder, and B. Božič Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I Clin. Chem. Lab. Med. 42 2004 171 174
32. K. Ichikawa, A. Tsutsumi, T. Atsumi, E. Matsuura, S. Kobayashi, and G.R. Hughes A chimeric antibody with the human gamma 1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I dependent anticardiolipin and anti-beta2-glycoprotein I antibodies Arthritis Rheum. 42 1999 2461 2470
33. S. Čučnik, A. Ambrožič, B. Božič, M. Skitek, and T. Kveder Anti-β2glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards Clin. Chem. Lab. Med. 38/8 2000 777 783
34. T. Avčin, A. Ambrožič, B. Božič, M. Accetto, T. Kveder, and B. Rozman Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis Clin. Exp. Rheumatol. 20 2002 101 108
35. A. Ambrožič, T. Kveder, B. Božič, and B. Rozman Comparison of different kits in the detection of autologous to cardiolipin and beta2-glycoprotein 1: comment on the article by Audrain et al. Rheumatol. (Oxf. Print) 43 8 2004 1062 1063
36. G. Reber, and P. de Moerloose Anti-β2-glycoprotein I antibodies-when and how should be measured? Thromb. Res. 114 2004 527 531
37. M.C. Velasquillo, J. Alocer-Varela, D. Alarcon-Segovia, J. Cabiedes, and J. Sanchez-Guerrero Some patients with primary antiphospholipid syndrome have increased circulating CD5+B cells that correlate with levels of IgM antiphospholipid antibodies Clin. Exp. Rheumatol. 9 1991 501 505
38. P. Lieby, A. Soley, A.M. Knapp, M. Cerutti, J.M. Freysinet, and J.L. Pasquali Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals Blood 102 2003 2459 2465
39. P. Youinou, and Y. Renaudineau The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases Thromb. Res. 114 2004 363 369
40. S. Čučnik, T. Kveder, B. Rozman, and B. Božič Binding of high-avidity anti-beta2-glycoprotein I antibodies Rheumatology (Oxford. Print) 43 2004 1353 1356